Nuclear Medicine

Doç. Dr. Arif Kürşad Ayan

Doctor and researcher Medicana International Samsun Samsun
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which topics does this doctor work on?

From source

Medical areas of interest stated by the doctor on the institution profile. Source: medicana.com.tr.

  • PET/BT ve Sintigrafik Tetkikler
  • Radyonüklid Tedaviler

CV

Education and experience

From source

Education

  • 2002Cerrahpaşa Tıp Fakültesimedicana.com.tr
  • 2010Atatürk Üniversitesi Tıp Fakültesimedicana.com.tr
  • 2010-2017Atatürk Üniversitesi Tıp Fakültesimedicana.com.tr
  • 2018-2024Muğla Özel Yücelen Hastanesimedicana.com.tr

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyNuclear Medicinemedicana.com.trFrom source
  • InstitutionMedicana International Samsunmedicana.com.trFrom source
  • Publications6 publicationsmedicana.com.tr profile pageFrom source
  • Last synchronised7 November 2026 03:23https://www.medicana.com.tr/hekim-detay/22472/arif-kursad-ayanmedicana.com.tr

Scientific work

Publications

6 publications

  1. The Relationship of SUV Value in PET-CT with Tumor Differentiation and Tumor Markers in Gastric Cancer. Maman A, Sahin A, Ayan AK. Eurasian J Med. 2020 Feb;52(1):67-72. doi: 10.5152/eurasianjmed.2019.19016.

    Source: medicana.com.tr profile page

  2. Evaluation of radiolabeled curcumin-loaded solid lipid nanoparticles usage as an imaging agent in liver-spleen scintigraphy. Ayan AK, Yenilmez A, Eroglu H. Mater Sci Eng C Mater Biol Appl. 2017 Jun 1;75:663-670. doi: 10.1016/j.msec.2017.02.114. Epub 2017 Feb 24.

    Source: medicana.com.tr profile page

  3. Value of dynamic MRI using the Ktrans technique for assessment of native kidneys in pre-emptive renal transplantation. Sade R, Kantarci M, Karaca L, Okur A, Ogul H, Keles M, Çankaya E, Ayan AK. Acta Radiol. 2017 Aug;58(8):1005-1011. doi: 10.1177/0284185116678272. Epub 2016 Nov 19.

    Source: medicana.com.tr profile page

  4. Comparison of glomerular filtration rate measurements with the two-plasma sample technique using Tc-99m DTPA and other methods in donor candidates for renal transplantation. Ayan AK, Varoğlu E, Keleş M, Seven B, Uyanik A, Örsal E. Turk J Med Sci. 2016 Jun 23;46(4):1025-32. doi: 10.3906/sag-1403-58.

    Source: medicana.com.tr profile page

  5. Is there any correlation between levels of serum ostepontin, CEA, and FDG uptake in lung cancer patients with bone metastasis? Ayan AK, Erdemci B, Orsal E, Bayraktutan Z, Akpinar E, Topcu A, Turkeli M, Seven B. Rev Esp Med Nucl Imagen Mol. 2016 Mar-Apr;35(2):102-6. doi: 10.1016/j.remn.2015.09.002. Epub 2015 Oct 27.

    Source: medicana.com.tr profile page

  6. Evaluation of bone metastasis as the first presentation of hepatocellular carcinoma using 18-fluorodeoxyglucose positron emission tomography-computed tomography. Ayan AK, Seven B, Orsal E, Demirci E. Indian J Nucl Med. 2013 Jul;28(3):171-2. doi: 10.4103/0972-3919.119552.

    Source: medicana.com.tr profile page